PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Nguyen, L. ; Schilling, D. ; Dobiasch, S. ; Raulefs, S. ; Santiago Franco, M. ; Buschmann, D.* ; Pfaffl, M.W.* ; Schmid, T.E. ; Combs, S.E.

The emerging role of miRNAs for the radiation treatment of pancreatic cancer.

Cancers 12:3703 (2020)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Today, pancreatic cancer is the seventh leading cause of cancer-related deaths worldwide with a five-year overall survival rate of less than 7%. Only 15–20% of patients are eligible for curative intent surgery at the time of diagnosis. Therefore, neoadjuvant treatment regimens have been introduced in order to downsize the tumor by chemotherapy and radiotherapy. To further increase the efficacy of radiotherapy, novel molecular biomarkers are urgently needed to define the subgroup of pancreatic cancer patients who would benefit most from radiotherapy. MicroRNAs (miRNAs) could have the potential to serve as novel predictive and prognostic biomarkers in patients with pancreatic cancer. In the present article, the role of miRNAs as blood biomarkers, which are associated with either radioresistance or radiation-induced changes of miRNAs in pancreatic cancer, is discussed. Furthermore, the manuscript provides own data of miRNAs identified in a pancreatic cancer mouse model as well as radiation-induced miRNA changes in the plasma of tumor-bearing mice.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.126
1.445
6
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Biomarker ; Mirna ; Pancreatic Cancer ; Personalized Medicine ; Radioresistance ; Radiotherapy ; Target; Cell Lung-cancer; Microrna Expression; Breast-cancer; Increases Radiosensitivity; Promotes Proliferation; Ductal Adenocarcinoma; Diagnostic Biomarkers; Potential Biomarker; Carcinoma-cells; Down-regulation
Language english
Publication Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 2072-6694
Journal Cancers
Quellenangaben Volume: 12, Issue: 12, Pages: , Article Number: 3703 Supplement: ,
Publisher MDPI
Publishing Place St Alban-anlage 66, Ch-4052 Basel, Switzerland
Reviewing status Peer reviewed
Institute(s) Institute of Radiation Medicine (IRM)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Radiation Sciences
PSP Element(s) G-501300-001
Grants KKF, Medical Faculty of the Technical University of Munich (TUM)
Helmholtz Zentrum Munchen
German Consortium for Translational Cancer Research
Hans und Klementia Langmatz Stiftung
Medical Faculty of the Technical University of Munich (TUM)
Deutsche Forschungsgemeinschaft (DFG, German Research foundation)
"Translational & Clinical Projects", Helmholtz Zentrum Munchen
Munich/TUM site
Medical Faculty of TUM
DOI 10.3390/cancers12123703
WOS ID WOS:000602227000001
Scopus ID 85098482418
PubMed ID 33317198
Erfassungsdatum 2021-02-05
[➜Report correction]